Win Drugs Ltd - Company Profile

It is a chemicals public limited company based in Delhi, Delhi, India, established in 2001.
2001 Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Win Drugs Ltd

Win Drugs Ltd, a struck off public limited company, was established on 12 October 2001 in Delhi, Delhi, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24231DL2001PLC112807. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.

Its leadership includes Ashok Kumar (Director), Kuldeep Suvesingh (Director), Naresh Kumar Mittal (Director). Past directors included Mahavir Singh. It holds no open charges and ₹4.70 M settled loans. Its latest AGM occurred on 30 September 2014, with the balance sheet filed on 31 March 2014. It is based at 25/A-47 Gali No 14Vishas Nagar Shadara, Delhi, Delhi, 110032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231DL2001PLC112807

  • Registration Number

    112807

  • Incorporation Date

    12 October 2001

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 24 Year, 5 Months
  • Last Filing with ROC 31 Mar 2014
  • Satisfied Charges ₹ 4.70 M
Company report

Win Drugs Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Win Drugs Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Win Drugs Ltd?
Current Directors
Name Designation Appointment Date Status
Ashok Kumar Director 28 Dec 2004 Current
Kuldeep Suvesingh Director 17 Feb 2009 Current
Naresh Kumar Mittal Director 12 Oct 2001 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 18 Mar 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Win Drugs.

Enhance accessibility to Win Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Win Drugs revenue growth over time
Win Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Win Drugs?

Unlock access to Win Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹4,700,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of Patiala : 0.47 Cr
Latest Charge Details
Date Lender Amount Status
07 Feb 2008 State Bank Of Patiala ₹1.20 M Satisfied
15 Jul 2002 State Bank Of Patiala ₹1.00 M Satisfied
19 Jan 2002 State Bank Of Patiala ₹2.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Win Drugs?

Unlock and access historical data on people associated with Win Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Win Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Win Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Win Drugs
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 07 Feb 2008 via Charge ID 10099590 with State Bank Of Patiala was fully satisfied on 29 Jan 2015. was completed.

  • Charges

    A charge registered on 15 Jul 2002 via Charge ID 90369388 with State Bank Of Patiala was fully satisfied on 29 Jan 2015. was recorded as a recent event.

  • Charges

    The activity A charge registered on 19 Jan 2002 via Charge ID 90369363 with State Bank Of Patiala was fully satisfied on 29 Jan 2015. was completed.

  • Annual General Meeting

    Progress on Win Drugs Ltd last Annual general meeting of members was held on 30 Sep 2014 as per latest MCA records. was documented.

  • Balance Sheet

    Win Drugs Ltd has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Progress on Kuldeep Suvesingh was appointed as a Director was appointed as a Director on 17 Feb 2009 & has been associated with this company since 17 years 1 month . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Win Drugs Ltd?

The CIN of Win Drugs Ltd is U24231DL2001PLC112807.

Where is Win Drugs Ltd headquartered?

Win Drugs Ltd is headquartered at 25/A-47 Gali No 14Vishas Nagar Shadara, Delhi, Delhi, 110032.

When was Win Drugs Ltd incorporated?

Win Drugs Ltd was incorporated on 12 October 2001.

Who are the current directors of Win Drugs Ltd?

The current directors of Win Drugs Ltd are

What is the primary industry of Win Drugs Ltd?

The primary industry of Win Drugs Ltd is Chemicals.

Is Win Drugs Ltd a listed company?

Win Drugs Ltd is unlisted.

What is the capital structure of Win Drugs Ltd?

The authorized capital of Win Drugs Ltd is ₹1.00 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available